AI-generated summary
The authors pooled nine clinical trials of bright light therapy for nonseasonal depression and report a significant reduction in depressive symptoms overall. Benefit appeared strongest with 2 to 5 weeks of treatment used as monotherapy, while perinatal depression studies showed no significant improvement. The authors note moderate heterogeneity, inadequate blinding, small subgroup sizes, and no long-term follow-up.
- Studies included
- 9
- Who or what was studied
- Adults with nonseasonal depression, including perinatal depression subgroups
- Limits stated in the abstract
- The authors note moderate heterogeneity, inadequate participant blinding, small sample sizes in some subgroups, and no exploration of long-term effects.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Depression, Bright light therapy, Meta-analysis, Heterogeneity, Sample size. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.